221 related articles for article (PubMed ID: 32507575)
1. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.
Elnaem MH; Cheema E
Res Social Adm Pharm; 2021 Jan; 17(1):1938-1941. PubMed ID: 32507575
[TBL] [Abstract][Full Text] [Related]
2. FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.
Sousa Pinto G; Hung M; Okoya F; Uzman N
Res Social Adm Pharm; 2021 Jan; 17(1):1929-1933. PubMed ID: 33317767
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
Carico RR; Sheppard J; Thomas CB
Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 related regulatory change for pharmacists - The case for its retention post the pandemic.
Lynch M; O'Leary AC
Res Social Adm Pharm; 2021 Jan; 17(1):1913-1919. PubMed ID: 32893134
[TBL] [Abstract][Full Text] [Related]
5. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
Badreldin HA; Atallah B
Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
[TBL] [Abstract][Full Text] [Related]
6. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
[TBL] [Abstract][Full Text] [Related]
7. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
Merks P; Jakubowska M; Drelich E; Świeczkowski D; Bogusz J; Bilmin K; Sola KF; May A; Majchrowska A; Koziol M; Pawlikowski J; Jaguszewski M; Vaillancourt R
Res Social Adm Pharm; 2021 Jan; 17(1):1807-1812. PubMed ID: 32546449
[TBL] [Abstract][Full Text] [Related]
8. Creation of a Diabetes Pharmacists Network in Canada.
MacCallum L; Lewis GF
Can J Diabetes; 2017 Dec; 41(6):571-575. PubMed ID: 29224634
[No Abstract] [Full Text] [Related]
9. COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care.
Okoro RN
Res Social Adm Pharm; 2021 Jan; 17(1):1925-1928. PubMed ID: 33317766
[TBL] [Abstract][Full Text] [Related]
10. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
Cadogan CA; Hughes CM
Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
[TBL] [Abstract][Full Text] [Related]
11. The impact of COVID-19 on pharmacy transitions of care services.
Herzik KA; Bethishou L
Res Social Adm Pharm; 2021 Jan; 17(1):1908-1912. PubMed ID: 33162381
[TBL] [Abstract][Full Text] [Related]
12. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
Front Public Health; 2020; 8():561924. PubMed ID: 33364224
[TBL] [Abstract][Full Text] [Related]
13. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
Aruru M; Truong HA; Clark S
Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists as mid-level practitioners/providers.
Ross LA
Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a pharmacist-managed diabetes program.
Jennings BT; Marx CM
Am J Health Syst Pharm; 2012 Nov; 69(22):1951-3. PubMed ID: 23135560
[No Abstract] [Full Text] [Related]
16. The role of a Coronavirus disease 2019 pharmacist: an Australian perspective.
Nguy J; Hitchen SA; Hort AL; Huynh C; Rawlins MDM
Int J Clin Pharm; 2020 Oct; 42(5):1379-1384. PubMed ID: 32472325
[TBL] [Abstract][Full Text] [Related]
17. Role of pharmacist during the COVID-19 pandemic: A scoping review.
Visacri MB; Figueiredo IV; Lima TM
Res Social Adm Pharm; 2021 Jan; 17(1):1799-1806. PubMed ID: 33317760
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of the pharmacist in global health.
Steeb DR; Joyner PU; Thakker DR
J Am Pharm Assoc (2003); 2014; 54(5):552-5. PubMed ID: 25216886
[TBL] [Abstract][Full Text] [Related]
19. In search of patients for pharmaceutical care.
Bouvy ML
Int J Pharm Pract; 2013 Aug; 21(4):205-6. PubMed ID: 23841805
[No Abstract] [Full Text] [Related]
20. Pharmacists-resource-friendly outcome improvement partners in health care delivery.
Clay PG
J Am Pharm Assoc (2003); 2017; 57(3):419-420. PubMed ID: 28506402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
